Back to today’s briefing

Story perspectives

China Unveils Innovative Drug Catalog, Boosts Access to 19 Medicines

12/7/2025

50 8

Summary

Story summary

Eli Lilly and Company, Pfizer Inc., and Johnson & Johnson have been included in China's first innovative drug catalog.
The catalog features 19 medicines for conditions like cancer and Alzheimer’s.
Drugmakers negotiated discounts of 15% to 50% for private insurers.
Analysts expect the catalog could expand to 300 drugs by 2027.
The new catalog and the latest National Reimbursement Drug List update take effect on January 1.

1 of 1

Story summary

Eli Lilly and Company, Pfizer Inc., and Johnson & Johnson have been included in China's first innovative drug catalog.
The catalog features 19 medicines for conditions like cancer and Alzheimer’s.
Drugmakers negotiated discounts of 15% to 50% for private insurers.
Analysts expect the catalog could expand to 300 drugs by 2027.
The new catalog and the latest National Reimbursement Drug List update take effect on January 1.